nodes	percent_of_prediction	percent_of_DWPC	metapath
Scopolamine—ABCB1—Dactinomycin—muscle cancer	0.216	0.34	CbGbCtD
Scopolamine—ABCB1—Vincristine—muscle cancer	0.133	0.21	CbGbCtD
Scopolamine—ABCB1—Etoposide—muscle cancer	0.122	0.192	CbGbCtD
Scopolamine—ABCB1—Doxorubicin—muscle cancer	0.0833	0.131	CbGbCtD
Scopolamine—ABCB1—Methotrexate—muscle cancer	0.0806	0.127	CbGbCtD
Scopolamine—CHRM3—muscle of abdomen—muscle cancer	0.0647	0.28	CbGeAlD
Scopolamine—SI—embryo—muscle cancer	0.0438	0.189	CbGeAlD
Scopolamine—SI—head—muscle cancer	0.0222	0.0957	CbGeAlD
Scopolamine—SI—testis—muscle cancer	0.0214	0.0925	CbGeAlD
Scopolamine—CHRM4—head—muscle cancer	0.0109	0.0473	CbGeAlD
Scopolamine—CHRM4—testis—muscle cancer	0.0106	0.0457	CbGeAlD
Scopolamine—CHRM5—head—muscle cancer	0.00855	0.0369	CbGeAlD
Scopolamine—CHRM3—smooth muscle tissue—muscle cancer	0.00743	0.0321	CbGeAlD
Scopolamine—CHRM3—renal system—muscle cancer	0.00715	0.0309	CbGeAlD
Scopolamine—CHRM2—head—muscle cancer	0.00587	0.0254	CbGeAlD
Scopolamine—CHRM1—head—muscle cancer	0.00535	0.0231	CbGeAlD
Scopolamine—Abdominal cramps—Vincristine—muscle cancer	0.00491	0.0369	CcSEcCtD
Scopolamine—CHRM3—head—muscle cancer	0.00478	0.0207	CbGeAlD
Scopolamine—CHRM3—testis—muscle cancer	0.00462	0.02	CbGeAlD
Scopolamine—ABCB1—embryo—muscle cancer	0.00367	0.0159	CbGeAlD
Scopolamine—ABCB1—renal system—muscle cancer	0.00278	0.012	CbGeAlD
Scopolamine—Dysphagia—Dactinomycin—muscle cancer	0.00233	0.0175	CcSEcCtD
Scopolamine—Urinary retention—Vincristine—muscle cancer	0.00229	0.0172	CcSEcCtD
Scopolamine—Muscular weakness—Vincristine—muscle cancer	0.00212	0.016	CcSEcCtD
Scopolamine—ABCB1—bone marrow—muscle cancer	0.0021	0.00908	CbGeAlD
Scopolamine—Redness—Doxorubicin—muscle cancer	0.00206	0.0155	CcSEcCtD
Scopolamine—ABCB1—vagina—muscle cancer	0.00201	0.0087	CbGeAlD
Scopolamine—Dysuria—Vincristine—muscle cancer	0.00195	0.0146	CcSEcCtD
Scopolamine—Speech disorder—Methotrexate—muscle cancer	0.00187	0.0141	CcSEcCtD
Scopolamine—ABCB1—head—muscle cancer	0.00186	0.00804	CbGeAlD
Scopolamine—Pharyngitis—Dactinomycin—muscle cancer	0.00185	0.0139	CcSEcCtD
Scopolamine—Amblyopia—Doxorubicin—muscle cancer	0.0018	0.0136	CcSEcCtD
Scopolamine—ABCB1—testis—muscle cancer	0.0018	0.00776	CbGeAlD
Scopolamine—Sweating—Vincristine—muscle cancer	0.00178	0.0134	CcSEcCtD
Scopolamine—Flushing—Dactinomycin—muscle cancer	0.00173	0.013	CcSEcCtD
Scopolamine—Dysphagia—Etoposide—muscle cancer	0.00169	0.0127	CcSEcCtD
Scopolamine—Hallucination—Vincristine—muscle cancer	0.00166	0.0125	CcSEcCtD
Scopolamine—Urinary tract disorder—Vincristine—muscle cancer	0.00164	0.0124	CcSEcCtD
Scopolamine—Urethral disorder—Vincristine—muscle cancer	0.00163	0.0123	CcSEcCtD
Scopolamine—Erythema—Dactinomycin—muscle cancer	0.00162	0.0122	CcSEcCtD
Scopolamine—Depressed level of consciousness—Methotrexate—muscle cancer	0.00155	0.0117	CcSEcCtD
Scopolamine—Mental disorder—Vincristine—muscle cancer	0.00146	0.011	CcSEcCtD
Scopolamine—Urinary tract disorder—Etoposide—muscle cancer	0.00133	0.01	CcSEcCtD
Scopolamine—Agitation—Vincristine—muscle cancer	0.00133	0.01	CcSEcCtD
Scopolamine—Oedema—Dactinomycin—muscle cancer	0.00132	0.00995	CcSEcCtD
Scopolamine—Urethral disorder—Etoposide—muscle cancer	0.00132	0.00994	CcSEcCtD
Scopolamine—Vertigo—Vincristine—muscle cancer	0.0013	0.00979	CcSEcCtD
Scopolamine—Dry eye—Doxorubicin—muscle cancer	0.00129	0.00967	CcSEcCtD
Scopolamine—Eye disorder—Etoposide—muscle cancer	0.00126	0.00947	CcSEcCtD
Scopolamine—Flushing—Etoposide—muscle cancer	0.00125	0.00941	CcSEcCtD
Scopolamine—Oedema—Vincristine—muscle cancer	0.00118	0.00889	CcSEcCtD
Scopolamine—Nervous system disorder—Vincristine—muscle cancer	0.00116	0.00872	CcSEcCtD
Scopolamine—Hyperhidrosis—Vincristine—muscle cancer	0.00114	0.00859	CcSEcCtD
Scopolamine—Fatigue—Dactinomycin—muscle cancer	0.00114	0.00858	CcSEcCtD
Scopolamine—Pain—Dactinomycin—muscle cancer	0.00113	0.00851	CcSEcCtD
Scopolamine—Eczema—Doxorubicin—muscle cancer	0.00113	0.00846	CcSEcCtD
Scopolamine—Irritability—Methotrexate—muscle cancer	0.00111	0.00838	CcSEcCtD
Scopolamine—Hypotension—Vincristine—muscle cancer	0.00111	0.00831	CcSEcCtD
Scopolamine—Feeling abnormal—Dactinomycin—muscle cancer	0.00109	0.0082	CcSEcCtD
Scopolamine—Vertigo—Etoposide—muscle cancer	0.00106	0.00793	CcSEcCtD
Scopolamine—Abdominal pain—Dactinomycin—muscle cancer	0.00105	0.00787	CcSEcCtD
Scopolamine—Body temperature increased—Dactinomycin—muscle cancer	0.00105	0.00787	CcSEcCtD
Scopolamine—Fatigue—Vincristine—muscle cancer	0.00102	0.00767	CcSEcCtD
Scopolamine—Pain—Vincristine—muscle cancer	0.00101	0.0076	CcSEcCtD
Scopolamine—Constipation—Vincristine—muscle cancer	0.00101	0.0076	CcSEcCtD
Scopolamine—Unspecified disorder of skin and subcutaneous tissue—Etoposide—muscle cancer	0.000993	0.00746	CcSEcCtD
Scopolamine—Confusional state—Etoposide—muscle cancer	0.000966	0.00726	CcSEcCtD
Scopolamine—Asthenia—Dactinomycin—muscle cancer	0.00095	0.00714	CcSEcCtD
Scopolamine—Dysuria—Methotrexate—muscle cancer	0.000944	0.00709	CcSEcCtD
Scopolamine—Tachycardia—Etoposide—muscle cancer	0.000935	0.00703	CcSEcCtD
Scopolamine—Body temperature increased—Vincristine—muscle cancer	0.000935	0.00703	CcSEcCtD
Scopolamine—Abdominal pain—Vincristine—muscle cancer	0.000935	0.00703	CcSEcCtD
Scopolamine—Skin disorder—Etoposide—muscle cancer	0.000931	0.007	CcSEcCtD
Scopolamine—Dry skin—Doxorubicin—muscle cancer	0.000927	0.00697	CcSEcCtD
Scopolamine—Hyperhidrosis—Etoposide—muscle cancer	0.000927	0.00696	CcSEcCtD
Scopolamine—Drowsiness—Methotrexate—muscle cancer	0.0009	0.00676	CcSEcCtD
Scopolamine—Hypotension—Etoposide—muscle cancer	0.000896	0.00673	CcSEcCtD
Scopolamine—Muscular weakness—Doxorubicin—muscle cancer	0.000892	0.0067	CcSEcCtD
Scopolamine—Conjunctivitis—Methotrexate—muscle cancer	0.000875	0.00657	CcSEcCtD
Scopolamine—Dysphagia—Doxorubicin—muscle cancer	0.000874	0.00657	CcSEcCtD
Scopolamine—Sweating—Methotrexate—muscle cancer	0.000863	0.00648	CcSEcCtD
Scopolamine—Somnolence—Etoposide—muscle cancer	0.000852	0.0064	CcSEcCtD
Scopolamine—Asthenia—Vincristine—muscle cancer	0.000849	0.00638	CcSEcCtD
Scopolamine—Vomiting—Dactinomycin—muscle cancer	0.000842	0.00633	CcSEcCtD
Scopolamine—Rash—Dactinomycin—muscle cancer	0.000835	0.00627	CcSEcCtD
Scopolamine—Fatigue—Etoposide—muscle cancer	0.000826	0.00621	CcSEcCtD
Scopolamine—Pain—Etoposide—muscle cancer	0.00082	0.00616	CcSEcCtD
Scopolamine—Constipation—Etoposide—muscle cancer	0.00082	0.00616	CcSEcCtD
Scopolamine—Dysuria—Doxorubicin—muscle cancer	0.000817	0.00614	CcSEcCtD
Scopolamine—Pharyngitis—Methotrexate—muscle cancer	0.000802	0.00603	CcSEcCtD
Scopolamine—Urinary tract disorder—Methotrexate—muscle cancer	0.000798	0.006	CcSEcCtD
Scopolamine—Urethral disorder—Methotrexate—muscle cancer	0.000792	0.00595	CcSEcCtD
Scopolamine—Feeling abnormal—Etoposide—muscle cancer	0.00079	0.00593	CcSEcCtD
Scopolamine—Nausea—Dactinomycin—muscle cancer	0.000787	0.00591	CcSEcCtD
Scopolamine—Dizziness—Vincristine—muscle cancer	0.000782	0.00588	CcSEcCtD
Scopolamine—Drowsiness—Doxorubicin—muscle cancer	0.000779	0.00586	CcSEcCtD
Scopolamine—Visual impairment—Methotrexate—muscle cancer	0.000779	0.00585	CcSEcCtD
Scopolamine—Body temperature increased—Etoposide—muscle cancer	0.000758	0.00569	CcSEcCtD
Scopolamine—Abdominal pain—Etoposide—muscle cancer	0.000758	0.00569	CcSEcCtD
Scopolamine—Conjunctivitis—Doxorubicin—muscle cancer	0.000758	0.00569	CcSEcCtD
Scopolamine—Eye disorder—Methotrexate—muscle cancer	0.000755	0.00567	CcSEcCtD
Scopolamine—Vomiting—Vincristine—muscle cancer	0.000752	0.00565	CcSEcCtD
Scopolamine—Sweating—Doxorubicin—muscle cancer	0.000747	0.00561	CcSEcCtD
Scopolamine—Rash—Vincristine—muscle cancer	0.000746	0.00561	CcSEcCtD
Scopolamine—Dermatitis—Vincristine—muscle cancer	0.000745	0.0056	CcSEcCtD
Scopolamine—Headache—Vincristine—muscle cancer	0.000741	0.00557	CcSEcCtD
Scopolamine—Bradycardia—Doxorubicin—muscle cancer	0.000712	0.00535	CcSEcCtD
Scopolamine—Mental disorder—Methotrexate—muscle cancer	0.000708	0.00532	CcSEcCtD
Scopolamine—Erythema—Methotrexate—muscle cancer	0.000703	0.00529	CcSEcCtD
Scopolamine—Nausea—Vincristine—muscle cancer	0.000703	0.00528	CcSEcCtD
Scopolamine—Pharyngitis—Doxorubicin—muscle cancer	0.000694	0.00522	CcSEcCtD
Scopolamine—Urinary tract disorder—Doxorubicin—muscle cancer	0.000691	0.00519	CcSEcCtD
Scopolamine—Asthenia—Etoposide—muscle cancer	0.000688	0.00517	CcSEcCtD
Scopolamine—Urethral disorder—Doxorubicin—muscle cancer	0.000686	0.00515	CcSEcCtD
Scopolamine—Pruritus—Etoposide—muscle cancer	0.000678	0.0051	CcSEcCtD
Scopolamine—Visual impairment—Doxorubicin—muscle cancer	0.000674	0.00507	CcSEcCtD
Scopolamine—Vision blurred—Methotrexate—muscle cancer	0.000663	0.00498	CcSEcCtD
Scopolamine—Eye disorder—Doxorubicin—muscle cancer	0.000654	0.00491	CcSEcCtD
Scopolamine—Flushing—Doxorubicin—muscle cancer	0.000649	0.00488	CcSEcCtD
Scopolamine—Dizziness—Etoposide—muscle cancer	0.000634	0.00476	CcSEcCtD
Scopolamine—Vertigo—Methotrexate—muscle cancer	0.000632	0.00475	CcSEcCtD
Scopolamine—Arrhythmia—Doxorubicin—muscle cancer	0.000625	0.0047	CcSEcCtD
Scopolamine—Mental disorder—Doxorubicin—muscle cancer	0.000613	0.00461	CcSEcCtD
Scopolamine—Vomiting—Etoposide—muscle cancer	0.000609	0.00458	CcSEcCtD
Scopolamine—Erythema—Doxorubicin—muscle cancer	0.000609	0.00458	CcSEcCtD
Scopolamine—Rash—Etoposide—muscle cancer	0.000604	0.00454	CcSEcCtD
Scopolamine—Dermatitis—Etoposide—muscle cancer	0.000604	0.00454	CcSEcCtD
Scopolamine—Headache—Etoposide—muscle cancer	0.0006	0.00451	CcSEcCtD
Scopolamine—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—muscle cancer	0.000595	0.00447	CcSEcCtD
Scopolamine—Confusional state—Methotrexate—muscle cancer	0.000579	0.00435	CcSEcCtD
Scopolamine—Vision blurred—Doxorubicin—muscle cancer	0.000574	0.00431	CcSEcCtD
Scopolamine—Nausea—Etoposide—muscle cancer	0.000569	0.00428	CcSEcCtD
Scopolamine—Nervous system disorder—Methotrexate—muscle cancer	0.000563	0.00423	CcSEcCtD
Scopolamine—Agitation—Doxorubicin—muscle cancer	0.00056	0.00421	CcSEcCtD
Scopolamine—Skin disorder—Methotrexate—muscle cancer	0.000558	0.00419	CcSEcCtD
Scopolamine—Hyperhidrosis—Methotrexate—muscle cancer	0.000555	0.00417	CcSEcCtD
Scopolamine—Vertigo—Doxorubicin—muscle cancer	0.000547	0.00411	CcSEcCtD
Scopolamine—Hypotension—Methotrexate—muscle cancer	0.000536	0.00403	CcSEcCtD
Scopolamine—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—muscle cancer	0.000515	0.00387	CcSEcCtD
Scopolamine—Somnolence—Methotrexate—muscle cancer	0.00051	0.00384	CcSEcCtD
Scopolamine—Dry mouth—Doxorubicin—muscle cancer	0.000507	0.00381	CcSEcCtD
Scopolamine—Confusional state—Doxorubicin—muscle cancer	0.000501	0.00377	CcSEcCtD
Scopolamine—Oedema—Doxorubicin—muscle cancer	0.000497	0.00374	CcSEcCtD
Scopolamine—Fatigue—Methotrexate—muscle cancer	0.000495	0.00372	CcSEcCtD
Scopolamine—Pain—Methotrexate—muscle cancer	0.000491	0.00369	CcSEcCtD
Scopolamine—Nervous system disorder—Doxorubicin—muscle cancer	0.000488	0.00366	CcSEcCtD
Scopolamine—Tachycardia—Doxorubicin—muscle cancer	0.000485	0.00365	CcSEcCtD
Scopolamine—Skin disorder—Doxorubicin—muscle cancer	0.000483	0.00363	CcSEcCtD
Scopolamine—Hyperhidrosis—Doxorubicin—muscle cancer	0.000481	0.00361	CcSEcCtD
Scopolamine—Feeling abnormal—Methotrexate—muscle cancer	0.000473	0.00355	CcSEcCtD
Scopolamine—Hypotension—Doxorubicin—muscle cancer	0.000465	0.00349	CcSEcCtD
Scopolamine—Abdominal pain—Methotrexate—muscle cancer	0.000454	0.00341	CcSEcCtD
Scopolamine—Body temperature increased—Methotrexate—muscle cancer	0.000454	0.00341	CcSEcCtD
Scopolamine—Somnolence—Doxorubicin—muscle cancer	0.000442	0.00332	CcSEcCtD
Scopolamine—Fatigue—Doxorubicin—muscle cancer	0.000429	0.00322	CcSEcCtD
Scopolamine—Pain—Doxorubicin—muscle cancer	0.000425	0.00319	CcSEcCtD
Scopolamine—Constipation—Doxorubicin—muscle cancer	0.000425	0.00319	CcSEcCtD
Scopolamine—Asthenia—Methotrexate—muscle cancer	0.000412	0.0031	CcSEcCtD
Scopolamine—Feeling abnormal—Doxorubicin—muscle cancer	0.00041	0.00308	CcSEcCtD
Scopolamine—Pruritus—Methotrexate—muscle cancer	0.000406	0.00305	CcSEcCtD
Scopolamine—Abdominal pain—Doxorubicin—muscle cancer	0.000393	0.00295	CcSEcCtD
Scopolamine—Body temperature increased—Doxorubicin—muscle cancer	0.000393	0.00295	CcSEcCtD
Scopolamine—Dizziness—Methotrexate—muscle cancer	0.00038	0.00285	CcSEcCtD
Scopolamine—Vomiting—Methotrexate—muscle cancer	0.000365	0.00274	CcSEcCtD
Scopolamine—Rash—Methotrexate—muscle cancer	0.000362	0.00272	CcSEcCtD
Scopolamine—Dermatitis—Methotrexate—muscle cancer	0.000362	0.00272	CcSEcCtD
Scopolamine—Headache—Methotrexate—muscle cancer	0.00036	0.0027	CcSEcCtD
Scopolamine—Asthenia—Doxorubicin—muscle cancer	0.000357	0.00268	CcSEcCtD
Scopolamine—Pruritus—Doxorubicin—muscle cancer	0.000352	0.00264	CcSEcCtD
Scopolamine—Nausea—Methotrexate—muscle cancer	0.000341	0.00256	CcSEcCtD
Scopolamine—Dizziness—Doxorubicin—muscle cancer	0.000329	0.00247	CcSEcCtD
Scopolamine—Vomiting—Doxorubicin—muscle cancer	0.000316	0.00238	CcSEcCtD
Scopolamine—Rash—Doxorubicin—muscle cancer	0.000313	0.00236	CcSEcCtD
Scopolamine—Dermatitis—Doxorubicin—muscle cancer	0.000313	0.00235	CcSEcCtD
Scopolamine—Headache—Doxorubicin—muscle cancer	0.000311	0.00234	CcSEcCtD
Scopolamine—Nausea—Doxorubicin—muscle cancer	0.000295	0.00222	CcSEcCtD
